Article Details

NICE rejects molnupiravir, remdesivir and Evusheld as routine COVID-19 treatments

Retrieved on: 2022-11-16 16:15:25

Tags for this article:

Click the tags to see associated articles and topics

NICE rejects molnupiravir, remdesivir and Evusheld as routine COVID-19 treatments. View article details on HISWAI: https://pharmaceutical-journal.com/article/news/nice-rejects-molnupiravir-remdesivir-and-evusheld-as-routine-covid-19-treatments

Excerpt

Although there was evidence suggesting that molnupiravir and remdesivir were effective at treating COVID-19, the NICE committee said it did not ...

Article found on: pharmaceutical-journal.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up